Xenon Pharma Private Limited

Pharmaceutical company manufacturing various drugs and products.

2005 | Delhi (India) | Active
Last Updated:

Xenon Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 19 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -58.87%
  • Profit Growth -15.89%
  • Ebitda -16.93%
  • Net Worth 43.17%
  • Total Assets 14.07%

About Xenon Pharma

Xenon Pharma Private Limited (XPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 August 2005 and has a history of 19 years and eight months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Naresh Kumar and Karmveer Singh serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233DL2005PTC139951

  • Company No.

    139951

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    24 Aug 2005

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Xenon Pharma Private Limited offer?

Xenon Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Cardiovascular Drugs & Medication, Cholesterol Medicine, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Pharmaceutical Medicine, Brain & Nervous System Drugs, Antiepileptic Drugs, Blood Pressure Medicine.

Company report

Xenon Pharma Private Limited

Explore comprehensive data for Xenon Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Xenon Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Naresh Kumar Country flag representing In Director 19-Jan-2012Current
Karmveer Singh Country flag representing In Director 31-Mar-2018Current

Financial Performance of Xenon Pharma.

Xenon Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 58.87% decrease. The company also saw a substantial fall in profitability, with a 15.89% decrease in profit. The company's net worth Soared by an impressive increase of 43.17%.

Xenon Pharma revenue growth over time
Xenon Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-58.87%
Revenue from Operations
-58.88%
Total Assets
14.07%
Profit or Loss
-15.89%
Net Worth
43.17%
EBITDA
-16.93%

What is the Ownership and Shareholding Structure of Xenon Pharma?

In 2022, Xenon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Xenon Pharma?

Unlock and access historical data on people associated with Xenon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Xenon Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xenon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xenon Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Xenon Pharma

Recent activity within the organization

  • Annual General Meeting

    Xenon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Xenon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Director Appointment

    Karmveer Singh was appointed as a Director was appointed as a Director on 31 Mar 2018 & has been associated with this company since 7 years 1 month .

  • Director Appointment

    Naresh Kumar was appointed as a Director was appointed as a Director on 19 Jan 2012 & has been associated with this company since 13 years 3 months .

  • Company Incorporation

    Xenon Pharma Private Limited was registered on 24 Aug 2005 with Roc Delhi & aged 19 years 8 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Xenon Pharma Private Limited?

    Xenon Pharma Private Limited was incorporated on 24 Aug 2005.

  • What is authorized share capital and paid-up capital of Xenon Pharma Private Limited?

    The authorized share capital of Xenon Pharma Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Xenon Pharma Private Limited?

    Currently 2 directors are associated with Xenon Pharma Private Limited.

    • Naresh Kumar
    • Karmveer Singh
  • What is the registered address of Xenon Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Xenon Pharma Private Limited is Third Floor B-1 635, Janakpuri India, New Delhi, 110058.

  • What is the corporate identification number (CIN) and company number of Xenon Pharma Private Limited?

    The corporate identification number (CIN) of Xenon Pharma Private Limited is U24233DL2005PTC139951 and the company number is 139951 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Xenon Pharma Private Limited?

    The Official website of Xenon Pharma Private Limited is https://www.xenonpharma.in

  • What has been the recent revenue trend for Xenon Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Xenon Pharma Private Limited has fallen by -58.87%.

  • What change has been observed in the net worth of Xenon Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Xenon Pharma Private Limited has experienced an upsurge of 43.17%.

  • When was the last Balance Sheet of Xenon Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Xenon Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development